Fineline Cube

Follow:
14499 Articles
Henlius Biotech Starts Global Phase II Trial for PD-L1 ADC HLX43
CompanyDrug

Henlius Biotech Starts Global Phase II Trial for PD-L1 ADC HLX43

Tawada Healthcare Secures Series A+ Funding Led by Highlight Capital
CompanyDeals

Tawada Healthcare Secures Series A+ Funding Led by Highlight Capital

Merck's Pimicotinib NDA Accepted for Review by China's CDE
CompanyDrug

Merck’s Pimicotinib NDA Accepted for Review by China’s CDE

CSPC Pharma's SYS6040 ADC Gains FDA Clinical Trial Approval
CompanyDrug

CSPC Pharma’s SYS6040 ADC Gains FDA Clinical Trial Approval

State Council Issues Opinions to Advance Shenzhen's Healthcare Reforms
Policy / Regulatory

State Council Issues Opinions to Advance Shenzhen’s Healthcare Reforms

Eisai's Urece Arrives in Shanghai, Poised for Chinese Market Entry
CompanyDrug

Eisai’s Urece Arrives in Shanghai, Poised for Chinese Market Entry

Sanofi to Ship Beyfortus Ahead of RSV Season, Ensuring Global Availability
CompanyDrug

Sanofi to Ship Beyfortus Ahead of RSV Season, Ensuring Global Availability

Boai NKY's LYC001 Receives Clinical Approval in China for Advanced Solid Tumors
CompanyDrug

Boai NKY’s LYC001 Receives Clinical Approval in China for Advanced Solid Tumors

Sino Biopharmaceutical's TQB2868 Approved for Phase III Trial in Metastatic Pancreatic Cancer
CompanyDrug

Sino Biopharmaceutical’s TQB2868 Approved for Phase III Trial in Metastatic Pancreatic Cancer

Ocumension Therapeutics Gains CDE Approval for Phase III Presbyopia Trial
CompanyDrug

Ocumension Therapeutics Gains CDE Approval for Phase III Presbyopia Trial

Jiangxi Rimag Plans Acquisition of Changsha Zhongya Medical for RMB 29.5 Million
CompanyDeals

Jiangxi Rimag Plans Acquisition of Changsha Zhongya Medical for RMB 29.5 Million

Biogen Launches Qalsody in China for SOD1-ALS Treatment
CompanyDrug

Biogen Launches Qalsody in China for SOD1-ALS Treatment